Parietex Progrip Study

November 16, 2016 updated by: Medtronic - MITG

ProGrip Mesh Repair Versus Lichtenstein Mesh Repair: a Comparative Randomized Study in Primary Inguinal Hernia

The objective of the study is to evaluate pain and disabling complications inducing social consequences in primary inguinal hernia ProGrip mesh repair compared to Lichtenstein repair with lightweight polypropylene mesh.

Study Overview

Detailed Description

  • Patients in ProGrip group will be treated with self-gripping lightweight Polyester and Polylactic acid meshes providing a sutureless fixation.
  • Patients in Lichtenstein group will be treated with lightweight Polypropylene meshes requiring fixation by sutures.
  • Study participation will start at signature of informed consent and each patient will be assessed before surgery. A close follow-up will be performed: 7 days (questionnaires and phone call), 1 month (clinical visit), 3 months (questionnaires and phone call), and final evaluation at 12 months (clinical visit) after surgery, which will end the participation to the study.
  • 600 adult males divided in 2 groups requiring primary uncomplicated elective inguinal hernia mesh repair will be included in the study. Patients will be stratified by center.

Study Type

Interventional

Enrollment (Actual)

603

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium, 3000
        • Universitaire Ziekenhuizen Leuven
      • Bremen, Germany, 28177
        • Klinikum Bremen-Mitte
      • Fulda, Germany, D- 36039 Fulda
        • Herz-Jesu-Krankenhaus gGmbH, Chirurgische Klinik
      • Eindhoven, Netherlands, 5623 EJ
        • Catharina-Ziekenhuis
      • Linköping, Sweden, 582 24
        • Medical Center Linköping
      • Västeras-, Sweden, 721 89
        • Centre of clinical research
      • Glasgow, United Kingdom, G11 6NT
        • Western Infirmary
      • London, United Kingdom, W2 1NY
        • Imperial College London / Faculty of Medecine
      • Plymouth, United Kingdom, PL6
        • Derriford Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

31 years to 74 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • All male patients at participating centers with a primary, uncomplicated inguinal hernia.
  • Collar of the defect ≤ 4 cm
  • Signed informed consent

Exclusion Criteria:

  • 30 years ≥ Age ≥ 75 years
  • Emergency procedure
  • Inclusion in other trials
  • Bilateral inguinal hernia
  • Recurrence

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: 1
Parietex ProGrip

Surgical technique:

Self-gripping lightweight Polyester and Polylactic acid meshes providing a sutureless fixation.

ACTIVE_COMPARATOR: 2
Low weight polypropylene mesh

Surgical technique:

Lichtenstein repair with lightweight polypropylene mesh (inferior to 70gr/m2) secured to the posterior inguinal wall with sutures

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Assessment During the First Three Months and at One Year After Surgery Using a Visual Analogue Scale (VAS)
Time Frame: M3, M12 after surgery
Pain assessment during patient follow up after surgery using VAS score. VAS going from 0 mm (no pain) to 150 mm (worst conceivable pain) is presented to the patient who draw a vertical line on the scale to indicate the average amount of pain at the time of consultation or at home.
M3, M12 after surgery
Pain Assessment During the First Three Months and at One Year After Surgery Using a Surgical Pain Scales (SPS)
Time Frame: M3, M12 after surgery
Surgical pain scales (=SPS) completed by patient during consultation or will be sent to the patient with instructions to complete it and send it back by mailing. The score of evaluation will be reported in mm, specifying if pain occurs at rest, during normal activities, during exercise. The score is ranged from 0 (no pain) to 150 mm (the worst pain yu have never known).
M3, M12 after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foreign Body Sensation
Time Frame: M1, M3, M12 months after surgery
Foreign body sensation using a specific questionnaire at M1, M3, M12 months after surgery. Questionnaire will be completed by patient during consultation or will be sent to the patient with instructions to complete it and send it back by mailing.
M1, M3, M12 months after surgery
Chronic Pain Defined as Pain Lasting More Than 3 Months Using VAS Score
Time Frame: 3 months after surgery
Chronic pain defined as pain lasting more than 3 months using VAS score. A VAS going from 0 mm (no pain) to 150 mm (worst conceivable pain) is presented to the patient who draw a vertical line on the scale to indicate the average amount of pain at the time of consultation or at home.
3 months after surgery
Wound Complications and Hernia Recurrences
Time Frame: M12 after surgery
M12 after surgery
Return to Work and to Normal Daily Activities
Time Frame: Effective date
Effective date
Other Post-operative Complications
Time Frame: M12 after surgery
M12 after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2008

Primary Completion (ACTUAL)

October 1, 2012

Study Completion (ACTUAL)

October 1, 2012

Study Registration Dates

First Submitted

January 22, 2009

First Submitted That Met QC Criteria

January 22, 2009

First Posted (ESTIMATE)

January 23, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

November 17, 2016

Last Update Submitted That Met QC Criteria

November 16, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • SC 0607/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hernia, Inguinal

Clinical Trials on Parietex Progrip

Subscribe